Table III.
Univariate | Full Multivariable | Reduced Multivariable | |||||
---|---|---|---|---|---|---|---|
Frequency | Mean Change (SE) | p-value | Mean Change (SE) | p-value | Mean Change (SE) | p-value | |
HLA DR-DQ Haplotypes | |||||||
*0101-*0101-*0501 | 0.164 | −0.075 (0.035) | 0.033 | −0.09 (0.036) | 0.011 | −0.093 (0.036) | 0.009 |
*0102-*0101-*0501 | 0.032 | −0.171 (0.067) | 0.010 | −0.182 (0.067) | 0.007 | −0.186 (0.067) | 0.006 |
*1401-*0104-*0503 | 0.037 | 0.148 (0.069) | 0.032 | 0.115 (0.070) | 0.101 | - | - |
*1501-*0102-*0602 | 0.232 | −0.116 (0.029) | 6.52×10−5 | −0.125 (0.029) | 2.16×10−5 | −0.128 (0.029) | 1.17×10−5 |
Sex, Male (Female) | −0.064 (0.028) | 0.022 | −0.065 (0.028) | 0.019 | |||
Study Site (Atlanta, GA) | |||||||
Birmingham, AL | −0.074 (0.043) | 0.084 | −0.077 (0.042) | 0.070 | |||
Houston, TX | −0.134 (0.046) | 0.004 | −0.137 (0.046) | 0.003 | |||
Washington, DC | −0.085 (0.053) | 0.109 | −0.087 (0.053) | 0.100 | |||
Rochester, MN | −0.027 (0.042) | 0.510 | −0.023 (0.041) | 0.577 | |||
Age (< 30 years) | |||||||
30 to 39 years | −0.144 (0.040) | 2.97×10−4 | −0.144 (0.040) | 2.98×10−4 | |||
40 to 49 years | −0.239 (0.039) | 8.81×10−10 | −0.241 (0.039) | 5.73×10−10 | |||
50 to 61 years | −0.323 (0.044) | 2.11×10−13 | −0.323 (0.044) | 1.73×10−13 |
( ) denotes the reference category where applicable. Frequency denotes carriage frequency of particular haplotype based on N chromosomes. Mean change denotes the estimated regression coefficient representing the mean change in log10[AbPA] relative to the reference category based on a multivariable longitudinal model fit to measurements at 4, 8, 26, and 30 weeks. Regression coefficients for haplotype effects assume an additive effect on log10[AbPA] response. (SE) Standard error. All models also adjusted for route of administration, cumulative number of AVA doses, and time since last vaccination (See Methods).